Avamere Transitional Care And Rehabilitation Medicare and Medicaid Location: 2025 E Egbert St, Brighton, Colorado 80601 Ratings: Phone: (303) 659-4580 |
Riverdale Rehab And Care Community Of Brighton Medicare and Medicaid Location: 2311 E Bridge St, Brighton, Colorado 80601 Ratings: Phone: (303) 659-2253 |
News Archive
In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.
The Endocrine Society is hosting a Congressional briefing on November 4 to examine policies to help the 29 million Americans who have diabetes and the 86 million who are likely to develop the disease.
As men age, their testosterone levels decrease, but prior studies of the effects of administering testosterone to older men have been inconclusive. Now, research shows that testosterone treatment for men over 65 improves sexual function, walking ability and mood, according to a study published in the New England Journal of Medicine by team researchers from the Perelman School of Medicine at the University of Pennsylvania, and twelve other medical centers in the United States, in partnership with the National Institute on Aging.
GT Life Sciences, a privately held biotechnology company that utilizes a proven metabolic modeling and experimental platform to drive the discovery and design of new products and processes for the life sciences field, and BGI, the largest genomics organization in the world, announced that they have successfully completed for the first time the sequencing of the Chinese hamster ovary genome.
AstraZeneca and MSD (Merck) announced today that the U.S. Food and Drug Administration (FDA) has granted acceptance to file status of its application for the MEK inhibitor selumetinib, for use in patients with plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).
› Verified 6 days ago